RNS17 Apr 2023 10:49
Eden Research Plc
("Eden" or "Company")
Eden obtains authorisation for Mevalone in Poland
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces that its flagship biofungicide, Mevalone®, has received regulatory authorisation in Poland. The certification will allow farmers to apply Mevalone to their wine and table grapes to protect and treat outbreaks of Botrytis cinerea as well as on apples to prevent post-harvest storage diseases thereby helping to reduce food waste in the supply chain.
SumiAgro Europe has been appointed as the Company's exclusive distributor of Mevalone in the territory with product distribution expected to commence imminently. SumiAgro has extensive experience with Mevalone, having previously supported Eden with significant label extensions in France.
Poland represents a significant new market for Eden and the commercialisation of Mevalone, given it is the EU's largest producer of apples, producing almost 2.5 million tons annually. Eden expects to receive additional regulatory approvals in due course in additional Central European member states such as Germany, Austria, and Hungary, where high levels of wine production are found. Central Europe is a strategic target market for Eden with the ultimate addressable market for Eden's products being comparable in value to that of Southern Europe and potential sales of Mevalone estimated to peak at €3.2m.
Sign In
Follow the stocks
